Phase II trial of combination therapy with bevacizumab and S-1 in elderly patients with unresectable or recurrent colorectal cancer (BASIC).

Trial Profile

Phase II trial of combination therapy with bevacizumab and S-1 in elderly patients with unresectable or recurrent colorectal cancer (BASIC).

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Mar 2015

At a glance

  • Drugs Bevacizumab; Gimeracil/oteracil/tegafur
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms BASIC
  • Most Recent Events

    • 28 Mar 2012 Planned end date changed from 1 Mar 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
    • 20 Jun 2011 Planned end date changed from 1 Jun 2011 to 1 Mar 2012 as reported by ClinicalTrials.gov.
    • 28 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top